On May 13, 2026, Select Medical Holdings Corporation (SEM) was rated Neutral by Ann Hynes of Mizuho. With a current stock price of $16.45, this assessment reflects a modest price target of $16.50, suggesting minimal upside potential at this level. For investors, this rating indicates a period of cautious sentiment surrounding SEM, particularly as it navigates challenges in its earnings performance.
Recent Price Action
In recent trading sessions, SEM has exhibited relatively muted price movement, closing at $16.45, a decrease of 0.03%. The stock has faced notable volatility with a 52-week high of $28.07 and a low of $23.09. Today’s trading volume reached approximately 728,741 shares, significantly below its average volume of 2,302,225 shares, highlighting a lack of strong investor engagement. With a market capitalization of approximately $2.04 billion and a beta of 0.803, SEM has showcased stability relative to the broader market, yet the stock’s recent performance reflects a cautious investor sentiment amid fluctuating conditions.
Historical Performance
Examining SEM’s stock performance over several time frames reveals a mixed picture. Over the past month, SEM has seen a modest gain of 1.27%, while its quarterly performance improved by 13.52%. However, the stock has struggled over the past year, experiencing a drop of 20.75%. The stock’s weekly volatility stands at 2.19, with a monthly volatility of 1.9. These metrics indicate that while there is some recovery in shorter time frames, longer-term trends continue to signal weakness, especially in light of broader market conditions that have impacted the healthcare sector.
Earnings Analysis
The latest earnings report, released on April 30, 2026, brought forth disappointing results for SEM. The company reported earnings per share (EPS) of $0.35, missing expectations of $0.43 by approximately 18.6%. Although this marks an improvement from the previous quarter’s EPS of $0.16 (which also fell short of the estimated $0.23), the consistency of missing estimates could be a cause for concern regarding the quality and predictability of the company’s earnings. This trend might weigh on investor confidence going forward, particularly as analysts seek clearer signs of financial stability.
Analyst / Consensus View
Overall analyst sentiment for SEM is cautiously optimistic. The consensus rating sits at 90 days with three ratings total—one Buy and two Holds. The average price target among analysts is set at $18.50, with a high of $20 and a low of $16.50. Mizuho’s Neutral rating, paired with a price target closely matching the current market price, suggests analysts expect little movement in the stock in the short term. This indicates a period of stabilization as the company works to regain momentum.
Stock Grading or Fundamental View
The Stocks Telegraph Grade for Select Medical Holdings Corporation is currently set at 51, indicating a moderately solid investment profile but also reflecting certain vulnerabilities in its financial performance. This grade takes into account factors such as earnings quality, market position, and financial health, conveying that while SEM is a player in its sector, it may lack the robust fundamentals that drive higher confidence among risk-averse investors.
Conclusion
For investors considering SEM, the company appears to offer a moderate risk-reward proposition. Its current Neutral rating suggests that it may appeal to investors who are willing to accept short-term fluctuations for potential long-term recovery in a hybrid healthcare model. However, the mixed earnings outlook and recent performance trends indicate there might be better opportunities in more growth-oriented stocks. Investors should remain vigilant about SEM’s ability to improve its earnings predictability and navigate market challenges effectively. Overall, SEM may be a suitable option for those seeking exposure to the healthcare sector, albeit with an understanding of the associated risks.